Talk:Olanzapine
This page is not a forum for general discussion about Olanzapine. Any such comments may be removed or refactored. Please limit discussion to improvement of this article. You may wish to ask factual questions about Olanzapine at the Reference desk. |
Pharmacology B‑class High‑importance | ||||||||||
|
Medicine B‑class High‑importance | ||||||||||
|
/Archive 1 |
This page has archives. Sections older than 31 days may be automatically archived by Lowercase sigmabot III when more than 4 sections are present. |
Untitled
Here's an important article that just came out in the NY Times http://www.nytimes.com/2006/12/18/business/18drug.html?hp&ex=1166504400&en=abbfa89f1f363c93&ei=5094&partner=homepage — Preceding unsigned comment added by 71.206.230.233 (talk)
The Chemistry Section
Someone needs to explain in great detail using descriptive words to explain how this chemical is made or synthesized in language that the lay person can understand. A chart is not enough and the section alludes that there are many methods to synthesis this molecule so therefore all methods should be explained. 2602:306:C518:62C0:5C06:758E:E477:60D6 (talk) 23:18, 31 July 2012 (UTC)
- what purpose would that serve? — Preceding unsigned comment added by 82.45.216.153 (talk) 00:34, 15 January 2013 (UTC)
"Illegal promotion" paragraph removed
I've removed the paragraph below. I have no opinion on the drug or its use, or knowledge of the "qui tam" (class action) suits alleged, but it lacks clarity, citations, context, and doesn't make much sense. Please restore the paragraph if you have better sources and wording. 201.171.122.70 (talk) 09:13, 25 January 2013 (UTC)
- ===(removed paragraph) Illegal promotion in US===
- The criminal information alleged that Zyprexa was promoted (1999-2003) in nursing homes and assisted-living facilities for the treatment of disorders such as dementia, Alzheimer’s dementia, depression, anxiety, and sleep problems, and behavioral symptoms such as agitation, aggression, and hostility. The qui tam lawsuits alleged that Zyprexa was promoted (1999-2005) for use in patients of all ages and for the treatment of anxiety, irritability, depression, nausea, Alzheimer’s and other mood disorders. Off-label promotion of pharmaceutical drugs is considered, by the U.S. Food and Drug Administration (FDA), to be a serious crime that undermines their role in drug regulation and public safety.[1]
Adverse effects (deli nk)
Why did you undo my edit? 78.156.109.166 (talk) 08:31, 28 April 2013 (UTC)